Related Experiment Video
Updated: Mar 26, 2026
04:36
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
1.7K
Novelties in Diabetic Retinopathy.
Endocrine Development
|January 30, 2016
Summary
Diabetic retinopathy (DR) management has advanced with optical coherence tomography and anti-VEGF therapies for diabetic macular edema. Strict blood sugar control remains crucial for preventing vision loss from diabetes mellitus complications.
Area of Science:
- Ophthalmology
- Endocrinology
- Medical Imaging
Background:
- Diabetic retinopathy (DR) is a major cause of vision loss in diabetes mellitus patients.
- Advances in understanding DR pathophysiology have improved diagnosis and treatment.
- Diabetic macular edema is a key complication requiring effective management.
Purpose of the Study:
- To provide an overview of current and novel concepts in diabetic retinopathy.
- To discuss recent advances in DR diagnosis and treatment.
- To highlight promising therapeutic options for this sight-threatening condition.
Main Methods:
- Noninvasive retinal imaging using optical coherence tomography (OCT).
- Intraocular anti-vascular endothelial growth factor (anti-VEGF) antibody therapies.
- Intravitreal anti-inflammatory agents, including steroids.
Main Results:
- OCT facilitates high-resolution imaging and management of diabetic macular edema.
- Anti-VEGF therapies have become standard treatment, largely replacing laser photocoagulation.
- Steroid-based anti-inflammatory agents show effectiveness in intravitreal treatment.
Conclusions:
- Significant progress in DR diagnosis and treatment has been made.
- Anti-VEGF and anti-inflammatory therapies offer new hope for managing diabetic macular edema.
- Systemic glycemic control remains fundamental in preventing DR complications.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:20Pathophysiology of Diabetes
4.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.3K
01:25Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
01:15Diabetes: Management and Pharmacotherapy
1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
01:22Diabetes Mellitus: Type 2 and Gestational
5.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K